7/2/2026 1:13:39 PM NIH’s “All of Us” Milestone: Closing the Data Gap in AI Drug Repurposing By Antoinette Konski On June 30, 2026, the National Institutes of Health announced that its All of Us Research Program has become the world's largest...
6/29/2026 2:21:08 PM AI and Drug Repurposing: Old Drugs, New Tricks, and the IP Questions By Antoinette Konski A fascinating review article recently published in the Annual Review of Medicine by Fu et al. caught my attention for what it signals...
5/28/2026 5:06:08 PM Wealth Tax Watch: New York's Pied-à-Terre Tax Clears Final Legislative Hurdle — What Property Owners and Planners Need to Know By Josh Labat Faith Liveoak At a Glance New York State’s legislature is poised to approve a new annual tax on second homes in New York City valued at over $5...
5/15/2026 4:51:39 PM NMTC Summit Takeaways: Key Themes Foley Heard in Miami By Nick Kitzman Foley’s New Markets Tax Credit (NMTC) team attended the recent Cohn Reznick NMTC Summit in Miami, where community development entities...
3/9/2026 8:28:39 PM New Markets Tax Credit Financing: Subsidy for Health Care Facilities and Operations By Nick Kitzman Alan Kennard Enacted 25 years ago, the federal New Markets Tax Credit (NMTC) Program has become a powerful financing tool for health care...
3/9/2026 2:02:40 PM Targeted Healing Before Birth: Placenta-Derived Stem Cells in Prenatal Repair of Spinal Defects By Antoinette Konski Neural tube defects are among the most challenging congenital conditions in medicine, with a devastating burden on patients, families,...
3/5/2026 6:06:39 PM Prompt Injection: Social Engineering Attacks on AI By Steve Millendorf Today's AI models suffer from a critical flaw. They lack human judgment and context that makes them vulnerable to what security...
2/24/2026 9:52:11 PM Bridging AI and Clinical Reality: Lessons from the Mayo Clinic Platform in Precision Medicine By Antoinette Konski Artificial intelligence is no longer a peripheral tool in personalized medicine. AI is becoming a central driver of how diagnostics,...
2/24/2026 2:59:39 PM FDA Issues Draft Guidance on Using the “Plausible Mechanism” Framework to Develop Individualized Therapies for Rare Genetic Diseases By Antoinette Konski On February 23, 2026, the U.S. Food and Drug Administration (FDA) released its Draft Guidance for Industry, “Considerations for the Use...
2/9/2026 8:07:39 PM Federal Court Enjoins Oregon's Extended Producer Responsibility Law—a Bellwether Moment for All Seven EPR States By Nick Johnson Betsy Stone On February 6, a federal judge in Oregon quietly issued a two‑page order that might have initially appeared to be a mundane procedural...
1/28/2026 3:32:39 PM AI, Patents, and Precision Medicine: Highlights from Foley & Lardner's 2026 Health Care & Life Sciences Trends Report By Antoinette Konski The health care and life sciences sector is entering a period of accelerated transformation shaped by new technologies, shifting...
1/23/2026 11:58:39 PM USPTO Extends PPH Pilot Program to 2029 By Randy Pummill The U.S. Patent and Trademark Office (USPTO) has announced a significant extension of the IP5 Patent Prosecution Highway (PPH) pilot...
12/16/2025 9:50:09 PM The EU Digital Omnibus Regulation impact on the GDPR's Definition of Personal Data By Steve Millendorf On November 19, the European Commission introduced a draft regulation known as the Digital Omnibus Regulation (Omnibus Regulation), aimed...
12/11/2025 9:20:39 PM Antitrust Risks and Compliance Strategies in Intellectual Property Portfolio Management By Kate Gehl Richard Lee Ellen Matheson Kitty Young +1 more... Show less This article analyzes how intellectual property portfolio management can simultaneously promote innovation and present potential...
12/4/2025 3:50:10 PM FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation By Oyvind Dahle FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,...
12/1/2025 4:02:10 PM USPTO Updates Guidance on Inventorship in AI-assisted Inventions By Randy Pummill USPTO Director Squires released updated guidance on AI-assisted inventions. The new guidance states that AI-assisted inventions are...